+ All Categories
Home > Documents > David Adler Research Interests Pharmaceutics Solubility - Phenytoin in IV Solutions...

David Adler Research Interests Pharmaceutics Solubility - Phenytoin in IV Solutions...

Date post: 13-Dec-2015
Category:
Upload: herbert-walker
View: 218 times
Download: 0 times
Share this document with a friend
Popular Tags:
3
David Adler Research Interests Pharmaceutics Solubility - Phenytoin in IV Solutions Bioavailability/Clinical Equivalence - Sodium Warfarin - RCT Clinical Toxicology - Removal of Drugs by Hemodialysis Instrumentation Point – of – Care - Capillary Whole Blood Prothrombin Time/INR - Warfarin Capillary Whole Blood Activated Partial Thromboplastin Time - Heparin Drug Therapy Management in Chronic Disease – Outcomes of Collaborative Medication Management – RCT Curricular Impact on Student Quality of Life – Survey
Transcript

David AdlerResearch Interests

PharmaceuticsSolubility - Phenytoin in IV

SolutionsBioavailability/Clinical Equivalence - Sodium Warfarin - RCTClinical Toxicology - Removal of

Drugs by Hemodialysis

Instrumentation Point – of – Care - Capillary Whole Blood Prothrombin Time/INR -

Warfarin Capillary Whole Blood Activated

Partial Thromboplastin Time -

Heparin

Drug Therapy Management in Chronic Disease – Outcomes of Collaborative

Medication Management – RCT

Curricular Impact on Student Quality of Life – Survey

Access to Care in Underserved Communities – Hepatitis B

Core Expertise

Clinical Therapeutics - Anticoagulation - Others

Clinical Practice Base - Management of Chronic Disease Clinical Population

Applications of Point-of-Care Testing

Proposed Collaborations with SSPPS Faculty

Medication Therapy ManagementSpecialty Care Drug Therapy Management Primary Care Drug Therapy Management

Translational Opportunities in Patients with Venous Thromboembolic DiseaseSelect patient populations with:

Atrial FibrillationDeep Venous ThrombosisMechanical Heart Valves

Drug Interactions - Unanswered Questions:Natural Products – e.g. Mango influence on

elevating PT/INRDrug-Drug Interactions – MOA and Management

of Therapy


Recommended